Viewing Study NCT00922792


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-01 @ 2:13 PM
Study NCT ID: NCT00922792
Status: COMPLETED
Last Update Posted: 2016-05-13
First Post: 2009-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module